INIST ST CO., LTD is a prominent manufacturer dedicated to the development of raw material medicine and its synthesis technology since 2000. With a foundation rooted in change, innovation, and a passion for life, INIST ST has focused on researching and developing high-quality generic APIs and new salt IMDs (incrementally modified drugs), particularly beginning with cerebrovascular medicine. Their products cater to a growing demand for generic active pharmaceutical ingredients in the domestic market, while also witnessing a steady increase in overseas sales. Aiming to expand international outreach, INIST ST targets markets in the USA, Europe, and the Middle East.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)

INIST ST CO., LTD is committed to delivering exceptional pharmaceutical solutions and continues to explore opportunities for global expansion. For further information, please visit inist.co.kr.